Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 40, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-01
DOI
10.1186/s13046-021-01886-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS)
- (2021) Jeremy Lewin et al. EUROPEAN JOURNAL OF CANCER
- Dedifferentiated Liposarcoma: Systemic Therapy Options
- (2020) Zhubin Gahvari et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- 1629MO First-line chemotherapy (CT) in advanced well-differentiated/dedifferentiated liposarcoma (WD/DD LPS): An EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysis
- (2020) S. Stacchiotti et al. ANNALS OF ONCOLOGY
- Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody
- (2020) Silvia Martini et al. Cells
- Degree of MDM2 Amplification Affects Clinical Outcomes in Dedifferentiated Liposarcoma
- (2019) Kate Lynn J. Bill et al. ONCOLOGIST
- LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis
- (2019) Jin-Tian Miao et al. BIOSCIENCE REPORTS
- Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
- (2019) Ali Amin-Mansour et al. CLINICAL CANCER RESEARCH
- Oridonin induces Mdm2‐p60 to promote p53‐mediated apoptosis and cell cycle arrest in neuroblastoma
- (2019) Han‐Qing Zhu et al. Cancer Medicine
- Comparative Assessment of Antitumor Effects and Autophagy Induction as a Resistance Mechanism by Cytotoxics and EZH2 Inhibition in INI1-Negative Epithelioid Sarcoma Patient-Derived Xenograft
- (2019) Silvia Stacchiotti et al. Cancers
- Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression
- (2019) Shukun Han et al. CELL CYCLE
- HMGA2 enhances 5-fluorouracil chemoresistance in colorectal cancer via the Dvl2/Wnt pathway
- (2018) Xi Xu et al. Oncotarget
- Anti-tumor efficacy of Selinexor (KPT-330) in gastric cancer is dependent on nuclear accumulation of p53 tumor suppressor
- (2018) Vinod Vijay Subhash et al. Scientific Reports
- Let-7a could serve as a biomarker for chemoresistance against docetaxel in gastric cancer.
- (2018) Tohid Kazemi et al. Anti-Cancer Agents in Medicinal Chemistry
- The WNT10B network is associated with survival and metastases in chemoresistant triple-negative breast cancer
- (2018) Ikbale El Ayachi et al. CANCER RESEARCH
- Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study
- (2018) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial
- (2018) Javier Martin-Broto et al. LANCET ONCOLOGY
- Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour
- (2017) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth
- (2017) Marieke A. de Graaff et al. Translational Oncology
- Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
- (2017) Giovanni Luca Gravina et al. Oncotarget
- Molecular mechanism and therapeutic implications of selinexor (KPT-330) in liposarcoma
- (2016) Manoj Garg et al. Oncotarget
- Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
- (2016) Robert Nakayama et al. Oncotarget
- Myogenic Differentiation and Histologic Grading Are Major Prognostic Determinants in Retroperitoneal Liposarcoma
- (2015) Alessandro Gronchi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Amplified HMGA2 promotes cell growth by regulating Akt pathway in AML
- (2015) Li Tan et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Survivin – The inconvenient IAP
- (2015) Dario C. Altieri SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin
- (2015) Michelandrea De Cesare et al. Oncotarget
- HMGA2 Inhibits Apoptosis through Interaction with ATR-CHK1 Signaling Complex in Human Cancer Cells
- (2015) Suchitra Natarajan et al. NEOPLASIA
- Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour
- (2014) S. Stacchiotti et al. EUROPEAN JOURNAL OF CANCER
- XPO1 (CRM1) Inhibition Represses STAT3 Activation to Drive a Survivin-Dependent Oncogenic Switch in Triple-Negative Breast Cancer
- (2014) Y. Cheng et al. MOLECULAR CANCER THERAPEUTICS
- Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-a-vis Temozolomide and Antiangiogenics
- (2013) S. Stacchiotti et al. CLINICAL CANCER RESEARCH
- CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
- (2013) R. A. Salas Fragomeni et al. MOLECULAR CANCER THERAPEUTICS
- WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition
- (2013) Vickie Y. Jo et al. PATHOLOGY
- Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival
- (2011) A. Italiano et al. ANNALS OF ONCOLOGY
- Pleomorphic liposarcoma
- (2011) Markus P. Ghadimi et al. CANCER
- HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents
- (2011) D Palmieri et al. ONCOGENE
- A framework for oligonucleotide microarray preprocessing
- (2010) Benilton S. Carvalho et al. BIOINFORMATICS
- New frontiers in the treatment of liposarcoma, a therapeutically resistant malignant cohort
- (2010) Aviad Hoffman et al. DRUG RESISTANCE UPDATES
- Survivin withdrawal by nuclear export failure as a physiological switch to commit cells to apoptosis
- (2010) K-S Chan et al. Cell Death & Disease
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started